Zimmer Biomet said on Tuesday it would acquire medical device company Paragon 28 for about $1.1 billion to expand its portfolio of orthopedic surgical devices. The deal will give Zimmer Biomet access ...

Zimmer Biomet agrees to acquire Paragon 28 for $1.1 billion, with a non-tradeable CVR up to $1 per share. Deal expected to close in first half of 2025.

Paragon 28 (FNA) is up 8.3%, or $1.00 to $13.00.Invest with Confidence: Follow TipRanks' Top Wall Street Analysts to uncover their success rate ...

Expected to Enhance Zimmer Biomet's Financial Profile; Immediately Accretive to Revenue Growth and Accretive to Adjusted EPS within 24 Months of Deal Close WARSAW, Ind. and ENGLEWOOD, Colo.

Canaccord analyst Caitlin Cronin downgraded Paragon 28 (FNA) to Hold from Buy with a price target of $13, down from $15, after Zimmer Biomet ...

Zimmer Biomet announced that it plans to acquire Paragon 28, a medical device company, for approximately $1.1 billion. This acquisition is part of Zimmer's strategy to expand its orthopedic surgical ...

Zimmer Biomet made a major play in the foot and ankle treatment space today, announcing it will spend $1.2 billion to acquire Paragon 28.

End-Markets, with Expansion into ~$5 Billion Foot and Ankle Segment Expected to Enhance Zimmer Biomet's financial Profile; Immediately Accretive to Revenue Growth and Accretive to Adjusted EPS ...

Jan 28 (Reuters) - Zimmer Biomet (ZBH.N), opens new tab said on Tuesday it would acquire medical device company Paragon 28 (FNA.N), opens new tab for about $1.1 billion to expand its portfolio of ...